Company news
NovaBridge Biosciences news
Latest news releases, newest first.
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
October 28, 2026
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
October 25, 2026
Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
October 20, 2026